STADA

Strategy

Strategy

Three Pillar Strategy

STADA will be pursuing a three pillar strategy consisting of non-prescription OTC products, generics and specialty pharmaceuticals including biosimilars. The latter will focus on oncology, the central nervous system (CNS), diabetes and ophthalmology. Successful branded products are to become more internationalized in the future. As we already do, we will continue to offer a full portfolio in the generics segment.

New Markets

In developed markets, STADA will work on closing gaps regarding product portfolios and pillars of the business model. Among the new markets, the Middle East will receive a lot of attention.

Core Processes

All of STADA's core processes will undergo a thorough revision. Generating Synergies on a group level and becoming more agile will be the main goals.

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Lern more

Sustainability

Sustainability

For STADA "All the best" means taking responsibility.

Learn more

entdecken